mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma. (Q41561734)
Jump to navigation
Jump to search
scientific article published on 16 April 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma. |
scientific article published on 16 April 2016 |
Statements
mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma (English)
Suzan Stelloo
Joyce Sanders
Ekaterina Nevedomskaya
Jeroen de Jong
Dennis Peters
Geert J L H van Leenders
Guido Jenster